problemi i resheniya v bazisnoy terapii xobl

PDF 34 pages 1.6 MB Free download

34 pages

FaylHub.uz

Download via Telegram

Size 1.6 MB

File type PDF

Pages 34

Updated Dec 2025

Page preview (5 pages)

Scroll down 👇

1 / 34

powerpoint presentation problemi i resheniya v bazisnoy terapii xobl /ult/ppt/04.18/0 tolko dlya meditsinskix i farmatsevticheskix rabotnikov. dlya rasprostraneniya v mestax provedeniya meditsinskix ili farmatsevticheskix vistavok, seminarov, konferentsiy i inix podobnix meropriyatiy. professor m.a. xaritonov, zamestitel glavnogo pulmonologa mo rf, professor1 kafedri terapii (usovershenstvovaniya vrachey) voenno-meditsinskoy akademii , d.m.n sankt-peterburg 21 maya 2018 opredelenie i rasprostranennost xobl v mire v sootvetstvii s dannimi vsemirnoy organizatsii zdravooxraneniya (voz) xobl srednetyajelogo i tyajelogo techeniya stradayut 65 millionov chelovek2. ejegodno ot xobl umiraet okolo 3 mln chelovek, chto sostavlyaet 5% vsex prichin smerti2. 1. global strategy for the diagnosis, management and prevention of copd, global initiative for chronic obstructive lung disease (gold) 2018. http://www.goldcopd.org/ 2. http://www.who.int/respiratory/copd/burden/en/ xronicheskaya obstruktivnaya bolezn legkix (xobl) – rasprostranennoe zabolevanie, kotoroe mojno predotvratit i lechit, xarakterizuyusheesya persistiruyushimi respiratornimi simptomami i ogranicheniem skorosti vozdushnogo potoka, kotoroe svyazano s bronxialnimi i/ili alveolyarnimi narusheniyami, obichno vizivaemimi znachitelnim vozdeystviem povrejdayushix chastits ili gazov1 landis …

2 / 34

jeloe techenie xobl sredi lits starshe 40 let -10,1±4,8%. buist a., mcburnie m., vollmer w. et al. international variation in the prevalence of copd (the bold study): a population-based prevalence study. lancet, 2007, 370, 741-750. chuchalin et al international journal of copd 2014:9 963–974 diagnostika xobl faktori riska razvitiya xobl. vneshnie: kurenie, vliyanie promishlennoy biologicheskoy i mineralnoy pili, ximicheskix veshestv, zagryaznenie okrujayushey sredi vnutrennie: geneticheskaya predraspolojennost, narushenie rosta legochnoy tkani, nalichie bronxialnoy reaktivnosti ili astmi v anamneze, tyajelie respiratornie infektsii, perenesennie v detskom vozraste. jalobi i anamnez. simptomi xobl:  kashel (suxoy ili produktivniy)  narastayushaya odishka pri fizicheskoy nagruzke ili v pokoe preimushestvenno razvitie bolezni v vozraste starshe 40 let, chastota obostreniy xobl (0-1 nechastie obostreniya ili ≥2 – chastie obostreniya) dannie spirometricheskogo issledovaniya ofv1/fjel posle probi s bronxolitikom menee 0,7 – kriteriy postanovki diagnoza xobl opredelenie stepeni tyajesti narusheniya bronxialnoy proxodimosti: ot legkoy do krayne tyajeloy (spirometricheskaya klassifikatsiya …

3 / 34

obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ otsenka simptomov xobl:  modifitsirovannaya shkala mmrc (modified medical research council dyspnea scale): stepen virajennosti odishki. simptomi (odishka) schitayutsya virajennimi, esli bolnoy po shkale mmrc nabiraet 2 i bolee ballov1.  test cat (copd assessment test): vliyanie xobl na povsednevnuyu jizn i samochuvstvie patsientov. vklyuchaet 8 voprosov, pri rezultate 10 i bolee ballov, sleduet schitat, chto u bolnogo virajennie simptomi2 1. bestall jc, paul ea, garrod r, garnham r, jones pw, wedzicha ja: usefulness of the medical research council (mrc) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. thorax 1999; 54: 581–586. 2. jones pw, harding g, berry p, wiklund i, chen wh, kline leidy n: development and first validation of the copd assessment test. eur respir j 2009; 34: 648–654.  srednetyajelie obostreniya xobl (trebuyushie naznacheniya kortikosteroidnoy i/ili antibakterialnoy terapii)  tyajelie obostreniya (trebuyushie gospitalizatsii) otsenka obostreniy xobl global strategy …

4 / 34

vki diagnoza xobl otsenka dannix spirometrii pri xobl: global strategy for the diagnosis, management and prevention of copd, global initiative for chronic obstructive lung disease (gold) 2018. http://www.goldcopd.org/ federalnie klinicheskie rekomendatsii po lecheniyu xobl, 2017 http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ bronxodilatatsionniy test (proba s bronxolitikom)  400 mkg salbutamola (β2-agonist) → povtornaya spirometriya cherez 15-30 minut  bronxodilatatsionniy test schitaetsya polojitelnim, esli posle ingalyatsii bronxodilatatora koeffitsient bronxodilatatsii (kbd) po ofv1 sostavlyaet ne menee 12%, i pri etom absolyutniy prirost sostavlyaet 200 ml i bolee http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ kdba kdaxp ddaxp ddba ddba+ ddaxp igks + ddba ifde 4 kak vibrat preparat dlya terapii xobl? igks – ingalyatsionnie glyukokortikosteroidi ddba – dlitelno deystvuyushie β2-agonisti ddaxp – dlitelno deystvuyushie antixolinergicheskie preparati kdba – korotko deystvuyushie β2-agonisti kdaxp – korotko deystvuyushie antixolinergicheskie preparati ifde-4 – ingibitori fosfodiesterazi-4 opredelenie gruppi po gold global strategy for the diagnosis, management and prevention of copd, global …

5 / 34

ti obostreniy (srednetyajelix i tyajelix) redkie simptomi, redkie obostreniya redkie simptomi, chastie obostreniya chastie simptomi, chastie obostreniya chastie simptomi, redkie obostreniya otsenit effekt prodoljayushiesya simptomi gruppa a bronxolitik prodoljit, prekratit ili naznachit bronxolitik drugogo klassa gruppa b ddaxp ili ddba ddaxp + ddba povt. obostr. gruppa c ddaxp ddaxp + ddba ddba+igks povt. obostreniya gruppa d ddaxp dobavit roflumilast* dobavit makrolidi** ddaxp + ddba ddba + igks ddaxp + ddbaa + igks prodolj. simptomi, povt. obostr.) povt. obostr. gold 2018: vibor bazisnoy terapii xobl predpochtitelnaya terapiya global strategy for the diagnosis, management and prevention of copd, global initiative for chronic obstructive lung disease (gold) 2018. available from: http://www.goldcopd.org igks – ingalyatsionnie glyukokortikosteroidi ddba – dlitelno deystvuyushie β2-agonisti ddaxp – dlitelno deystvuyushie antixolinergicheskie preparati kdba – korotko deystvuyushie β2-agonisti kdaxp – korotko deystvuyushie antixolinergicheskie preparati ifde-4 – ingibitori fosfodiesterazi-4 vsem patsientam xobl v kachestve bazisnoy terapii pokazani bronxolitiki dlitelnogo deystviya v …

Want to read more?

Download all 34 pages for free via Telegram.

Download full file

About "problemi i resheniya v bazisnoy terapii xobl"

powerpoint presentation problemi i resheniya v bazisnoy terapii xobl /ult/ppt/04.18/0 tolko dlya meditsinskix i farmatsevticheskix rabotnikov. dlya rasprostraneniya v mestax provedeniya meditsinskix ili farmatsevticheskix vistavok, seminarov, konferentsiy i inix podobnix meropriyatiy. professor m.a. xaritonov, zamestitel glavnogo pulmonologa mo rf, professor1 kafedri terapii (usovershenstvovaniya vrachey) voenno-meditsinskoy akademii , d.m.n sankt-peterburg 21 maya 2018 opredelenie i rasprostranennost xobl v mire v sootvetstvii s dannimi vsemirnoy organizatsii zdravooxraneniya (voz) xobl srednetyajelogo i tyajelogo techeniya stradayut 65 millionov chelovek2. ejegodno ot xobl umiraet okolo 3 mln chelovek, chto sostavlyaet 5% vsex prichin smerti2. 1. global strategy for the diagnosis, manage...

This file contains 34 pages in PDF format (1.6 MB). To download "problemi i resheniya v bazisnoy terapii xobl", click the Telegram button on the left.

Tags: problemi i resheniya v bazisnoy… PDF 34 pages Free download Telegram

problemi i resheniya v bazisnoy terapii xobl

Page preview (5 pages)

Want to read more?

About "problemi i resheniya v bazisnoy terapii xobl"

Similar files